OA12089A - Novel thiazolidinedione derivatives as antidiabetic agents. - Google Patents

Novel thiazolidinedione derivatives as antidiabetic agents. Download PDF

Info

Publication number
OA12089A
OA12089A OA1200200148A OA1200200148A OA12089A OA 12089 A OA12089 A OA 12089A OA 1200200148 A OA1200200148 A OA 1200200148A OA 1200200148 A OA1200200148 A OA 1200200148A OA 12089 A OA12089 A OA 12089A
Authority
OA
OAPI
Prior art keywords
dione
ethoxy
thiazolidine
benzyl
compound
Prior art date
Application number
OA1200200148A
Other languages
English (en)
Inventor
Marisabel Mourelle Mancini
Juan Carlos Del Castillo Nieto
Elisabet De Ramon Amat
Original Assignee
Vita Invest Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vita Invest Sa filed Critical Vita Invest Sa
Publication of OA12089A publication Critical patent/OA12089A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Oncology (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
OA1200200148A 1999-11-18 2000-11-15 Novel thiazolidinedione derivatives as antidiabetic agents. OA12089A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009902533A ES2156574B1 (es) 1999-11-18 1999-11-18 Nuevos derivados de tiazolidindiona como agentes antidiabeticos

Publications (1)

Publication Number Publication Date
OA12089A true OA12089A (en) 2006-05-04

Family

ID=8310628

Family Applications (1)

Application Number Title Priority Date Filing Date
OA1200200148A OA12089A (en) 1999-11-18 2000-11-15 Novel thiazolidinedione derivatives as antidiabetic agents.

Country Status (37)

Country Link
US (1) US7001910B1 (zh)
EP (1) EP1231211B1 (zh)
JP (1) JP2003514817A (zh)
KR (1) KR100518110B1 (zh)
CN (1) CN1159314C (zh)
AP (1) AP1330A (zh)
AR (1) AR031080A1 (zh)
AT (1) ATE241622T1 (zh)
AU (1) AU770045B2 (zh)
BG (1) BG106699A (zh)
BR (1) BR0015613A (zh)
CA (1) CA2391913A1 (zh)
CO (1) CO5261560A1 (zh)
CR (1) CR6640A (zh)
CZ (1) CZ20021654A3 (zh)
DE (1) DE60003072T2 (zh)
DK (1) DK1231211T3 (zh)
EA (1) EA004301B1 (zh)
EE (1) EE200200254A (zh)
ES (2) ES2156574B1 (zh)
GE (1) GEP20043240B (zh)
HR (1) HRP20020426A2 (zh)
HU (1) HUP0203478A2 (zh)
IL (1) IL149634A0 (zh)
IS (1) IS2014B (zh)
MA (1) MA26844A1 (zh)
MX (1) MXPA02005011A (zh)
NO (2) NO20022336L (zh)
NZ (1) NZ519264A (zh)
OA (1) OA12089A (zh)
PE (1) PE20010858A1 (zh)
PL (1) PL354877A1 (zh)
PT (1) PT1231211E (zh)
SK (1) SK6752002A3 (zh)
WO (1) WO2001036416A1 (zh)
YU (1) YU40202A (zh)
ZA (1) ZA200203906B (zh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2174748B1 (es) * 2001-01-31 2003-09-16 Vita Lab Nueva sal de tiazolidindiona y sus polimorfos como agentes antidiabeticos y procedimiento para la obtencion de los mismos.
KR100450700B1 (ko) * 2002-03-22 2004-10-01 주식회사종근당 티아졸리딘디온 유도체 화합물 및 이를 함유하는 약제학적조성물
US7713983B2 (en) 2003-03-03 2010-05-11 Vertex Pharmaceuticals Incorporated Quinazolines useful as modulators of ion channels
CL2004000409A1 (es) * 2003-03-03 2005-01-07 Vertex Pharma Compuestos derivados de 2-(cilo sustituido)-1-(amino u oxi sustituido)-quinazolina, inhibidores de canales ionicos de sodio y calcio dependientes de voltaje; composicion farmaceutica; y uso del compuesto en el tratamiento de dolor agudo, cronico, neu
US20050014732A1 (en) * 2003-03-14 2005-01-20 Pharmacia Corporation Combination of an aldosterone receptor antagonist and an anti-diabetic agent
US8283354B2 (en) 2004-09-02 2012-10-09 Vertex Pharmaceuticals Incorporated Quinazolines useful as modulators of ion channels
US7928107B2 (en) 2004-09-02 2011-04-19 Vertex Pharmaceuticals Incorporated Quinazolines useful as modulators of ion channels
CZ297347B6 (cs) * 2004-09-21 2006-11-15 Zentiva, A. S. Zpusob prípravy rosiglitazonu
JP5546372B2 (ja) * 2010-06-30 2014-07-09 積水メディカル株式会社 ベンジルヒダントイン化合物の製造法
WO2016184895A1 (en) 2015-05-18 2016-11-24 Institut National De La Sante Et De La Recherche Medicale (Inserm) Means for detecting or measuring a biological activity of a botulinum toxin
US10689374B1 (en) 2019-07-12 2020-06-23 United Arab Emirates University Pyrimidine-thiazolidinone derivatives
US10702525B1 (en) * 2019-09-04 2020-07-07 United Arab Emirates University Pyrimidine derivatives as anti-diabetic agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR240698A1 (es) * 1985-01-19 1990-09-28 Takeda Chemical Industries Ltd Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
SG59988A1 (en) * 1987-09-04 1999-02-22 Beecham Group Plc Substituted thiazolidinedione derivatives
GB9023583D0 (en) * 1990-10-30 1990-12-12 Beecham Group Plc Novel compounds

Also Published As

Publication number Publication date
YU40202A (sh) 2006-01-16
EE200200254A (et) 2003-06-16
MA26844A1 (fr) 2004-12-20
KR100518110B1 (ko) 2005-10-04
ATE241622T1 (de) 2003-06-15
JP2003514817A (ja) 2003-04-22
WO2001036416A1 (es) 2001-05-25
NO20022379D0 (no) 2002-05-16
DE60003072T2 (de) 2004-04-01
AU770045B2 (en) 2004-02-12
MXPA02005011A (es) 2003-10-14
BR0015613A (pt) 2002-07-23
ES2156574A1 (es) 2001-06-16
GEP20043240B (en) 2004-05-25
EA200200470A1 (ru) 2002-10-31
PT1231211E (pt) 2003-09-30
IS2014B (is) 2005-06-15
NZ519264A (en) 2003-10-31
CO5261560A1 (es) 2003-03-31
AR031080A1 (es) 2003-09-10
NO20022336L (no) 2002-07-09
IL149634A0 (en) 2002-11-10
ES2156574B1 (es) 2002-02-01
ES2199878T3 (es) 2004-03-01
HRP20020426A2 (en) 2004-02-29
DK1231211T3 (da) 2003-10-27
BG106699A (bg) 2003-02-28
EA004301B1 (ru) 2004-02-26
DE60003072D1 (de) 2003-07-03
CA2391913A1 (en) 2001-05-25
PL354877A1 (en) 2004-03-08
AU1281501A (en) 2001-05-30
CN1402724A (zh) 2003-03-12
IS6386A (is) 2002-05-15
HUP0203478A2 (hu) 2003-02-28
KR20020079737A (ko) 2002-10-19
AP2002002512A0 (en) 2002-06-30
CR6640A (es) 2004-03-05
EP1231211A1 (en) 2002-08-14
US7001910B1 (en) 2006-02-21
NO20022336D0 (no) 2002-05-15
ZA200203906B (en) 2004-03-26
CZ20021654A3 (cs) 2002-09-11
CN1159314C (zh) 2004-07-28
AP1330A (en) 2004-11-25
PE20010858A1 (es) 2001-08-22
SK6752002A3 (en) 2002-09-10
EP1231211B1 (en) 2003-05-28

Similar Documents

Publication Publication Date Title
EP0306228B1 (en) Substituted thiazolidinedione derivatives
US6288095B1 (en) Compounds
US5391565A (en) Oxazolidine dione derivatives
US5260445A (en) 2,4-thiazolidinediones
US5075300A (en) Novel compounds
CA2163028C (en) New thiazolidinediones and pharmaceutical agents containing them
OA12089A (en) Novel thiazolidinedione derivatives as antidiabetic agents.
US6686475B2 (en) Compounds
EP0283036B1 (en) Benzoxazine derivatives and processes for preparation thereof
EP0787725B1 (en) Quinoline derivative
EP0801063B1 (en) Thiazolidinedione derivatives having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
KR100450700B1 (ko) 티아졸리딘디온 유도체 화합물 및 이를 함유하는 약제학적조성물
EP1868990A2 (en) Novel heterocyclic derivatives